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We report a case of a 60-year-old African American man who presented with a 4-year history of a previously asymptomatic,
recentlyenlargingnoduleonhisleftbuttock,whichwasinitiallypresumedtobeanepidermoidcyst.Physicalexaminationrevealed
a large, ﬁxed, subcutaneous tumor, and a biopsy revealed merkel cell carcinoma. Immunohistochemical staining was positive for
pankeratin, CAM 5.2, synaptophysin, and CD56 and negative for CK7, CK20, TTF-1, chromogranin, CD3, CD20, CD57, MART1,
and HMB 45. The patient underwent wide local excision of the lesion with removal of the fascia overlying the gluteus and full body
positron emission tomography (PET) and was found to have Stage IIb disease. He subsequently received adjuvant radiotherapy
l i m i t e dt ot h et u m o rb e da tad o s eo f6 0g r a y .
1. A Case Report
A60-year-oldAfricanAmericanmalepresentedwitha4-year
history of an asymptomatic stable nodule involving the left
buttock.Thelesionwasinitiallythoughttobeanepidermoid
cyst that did not require treatment. However, he returned
after the nodule rapidly increased in size over 2-3 months.
Physical examination revealed a 9 by 10 centimeter ﬁxed,
subcutaneous tumor with overlying hyperpigmentation and
slight scale (Figure 1).
A punch biopsy specimen demonstrated merkel cell
carcinoma (MCC) (Figure 2). Immunohistochemistry stains
were positive for pankeratin, CAM 5.2, synaptophysin, and
CD56 and negative for CK7, CK20, TTF-1, chromogranin,
CD3, CD20, CD57, MART1, and HMB 45. Full body
positron emission tomography (PET) demonstrated uptake
at the sight of the tumor and a local inguinal node. The
patient underwent wide local excision of the mass with
removal of the fascia overlying the gluteus. The underlying
stripped muscle was grossly negative. The abnormal node
on PET was identiﬁed as the sentinel lymph node and
was negative, both by ﬁne needle aspiration and excision.
Upon pathologic review, the tumor involved only the deep
margin. Therefore, he was diagnosed with Stage IIb MCC
(pT3N0M0). Given the positive deep margin, the patient
subsequently received adjuvant radiotherapy limited to the
tumor bed at a dose of 60 gray. Adjuvant chemotherapy was
not indicated per National Comprehensive Cancer Network
guidelines [1].
2. Discussion
MCC is an aggressive skin cancer usually noted on sun-ex-
posed sites of elderly Caucasian men. The disease-associated
mortality ranges from 33 to 50% [2, 3]. Merkel cells were
initially believed to originate from neural crest-derived
neuroendocrine cells; however, they are now thought to be
derived from pluripotent epidermal stem cells [4]. Most
MCC are likely induced by the merkel cell polyomavirus [3].
CK20 is the most frequently utilized immunohistochemical
stain used to diagnose MCC and is positive in 89–100% of
cases [1].
Key clinical characteristics of MCC include patient
ethnicity, tumor location, and rate of tumor growth. The
vast majority of patients (∼98%) with MCC are white [2,
4, 5]. The most common tumor location involves the head
and neck in sun-exposed regions. In addition, rapid rate of
expansion (≤3 months) is often associated with MCC [2].2 Case Reports in Oncological Medicine
Figure 1: A 9 by 10 centimeter ﬁxed, subcutaneous tumor with
overlying hyperpigmentation and slight scale.
Figure 2: Ribbons of small, round, uniform blue cells with nuclear
molding (hematoxylin-eosin, original magniﬁcation ×100, inset:
original magniﬁcation ×400).
ImmunosuppressionisalsoariskfactorforMCC.Specif-
ically, patients with human immunodeﬁciency virus, chronic
lymphocyticleukemia,andsolidorgantransplantationareat
increased risk for MCC [2].
We report an unusual presentation of MCC initially
thought to be a benign slow growing cyst of the buttock
in an otherwise healthy 60-year-old African American male.
We highlight this case because of the patient’s ethnicity, the
length of time the tumor was present (four years) before
the rapid growth phase, the non-sun-exposed primary site,
and lack of immunosuppression. Furthermore, the tumor
was relatively large (9cm) and was negative for the CK 20
marker.
We aim to make dermatologists more aware of this
unique presentation of a slow-growing giant MCC in a non-
sun-exposed site of an African American patient.
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